From telomere loss to P53 induction and activation of a DNA-damage pathway at senescence: The telomere loss/DNA damage model of cell aging

Experimental Gerontology

Volumn 31, Issue 1-2, 1996, Pages 295-301

  Vaziri, Homayoun ^a   Benchimol, Sam ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

aging; DNA damage; p53; senescence; telomere

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; DNA; DNA POLYMERASE; EXONUCLEASE; MESSENGER RNA; NUCLEOPROTEIN; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; RIBONUCLEOPROTEIN; UBIQUITIN; VIRUS LARGE T ANTIGEN;

ARTICLE; CELL AGING; CELL CYCLE; CELL DIVISION; CHROMOSOME; DNA BINDING; DNA DAMAGE; DNA SYNTHESIS; GAMMA IRRADIATION; HUMAN; MITOSIS; MODEL; PRIORITY JOURNAL; SENESCENCE; TELOMERE;

EID: 0029924534     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/0531-5565(95)02025-X     Document Type: Article

References (42)

1. AFSHARI, C.A., VOJTA, P.J., ANNAB, L.A., FUTREAL, P.A., WILLARD, T.B., and BARRETT, C.J. Investigation of the Role of G1/S cell cycle mediators in cellular senescence. Exp. Cell Res. 209, 231-237, 1993.
2. ALLSOPP, R.C., VAZIRI, H., PATTERSON, C., GOLDSTEIN, S., YOUNGLAI, E.V., FUTCHER, A.B., GREIDER, C.W., and HARLEY, C.B. Telomere length predicts the replicative capacity in human fibroblasts. Proc. Natl. Acad. Sci. USA 89, 10114-10118, 1992.
3. ALLSOPP, R.C. and HARLEY, Models of initiation of replicative senescence by loss of telometric DNA. (This issue).
4. ATADJA, P., WONG, H., GARKAVSTEV, I., VEILLETTE, C., and RIABOWOL, K. Proc. Natl. Acad. Sci. USA 92, 8348-8352, 1995.
5. BENN, P. Specific chromosome alterations in senescent fibroblast cell lines derived from human embryos. Am. J. Hum. Genet. 28, 465-473, 1976.
6. BISCHOFF, F.Z., YIM, S.O., PATHAK, S., GRANT, G., SICILIANO, M.J., GIOVANELLA, B.C., STRONG, L.C., and TAINSKY, M.A. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni syndrome: Aneuploidy and immortalization. Cancer Res. 50, 7979-7984, 1990.
7. BLACKBURN, E.H. The structure and function of telomeres. Nature 350, 569-573, 1991.
8. COUNTER, C.M., AVILION, A.A., LE FEUVRE, C.E., STEWART, N.G., GREIDER, C.W., HARLEY, C.B., and BACCHETTI, S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921-1929, 1992.
9. COUNTER, C.M., HIRTE, H., BACCHETTI, S., and HARLEY, C.B. Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. USA 91, 2900-2904, 1994.
10. Di LEONARDO, A.I., LINKE, S.P., CLARKIN, K., and WAHL, G.M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblast. Genes Dev. 8, 2540-2551, 1994.
11. DULIC, V., KAUFMANN, W.K., WILSON, S.J., TLSTY, T.D., LEES, E., HARPER, J.W., ELLEDGE, S.J., and REED, S.I. p53 dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during irradiation-induced G1 arrest. Cell 76, 1013-1023, 1994.
12. EL-DEIRY, W.S., TOKINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, E., KINZLER, K.W., and VOGELSTEIN, B. WAF1, a potent mediator of p53 tumor suppression. Cell 75, 817-825, 1993.
13. GOLDSTEIN, S. Replicative senescence: The human fibroblast comes of age. Science 249, 1129-1133, 1991.
14. GOLDSTEIN, S., MOERMAN, E.J., JONES, R.A. and BAXTER, R.C. Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of secescent and quiescent human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 88, 9680-9684, 1991.
15. GOTTSCHLING, D.E., APARICIO, O.M., BILLINGTON, B.L., and ZAKIAN, V.A. Position effect at S. cerevisiae telomeres: Reversible repression of Pol II transcription. Cell 63, 751-762, 1990.
16. GREIDER, C.W. and BLACKBURN, E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-414, 1985.
17. HARLEY, C.B., FUTCHER, A.B., and GREIDER, C.W. Telomeres shorten during aging of human fibroblasts. Nature 345, 458-460, 1990.
18. HARLEY, C.B. Telomere loss: Mitotic clock or genetic time bomb? Mutat. Res. 256, 271-282, 1991.
19. HASTIE, N.D., DEMPSTER, M., DUNLOP, M.G., THOMPSON, A.M., GREEN, D.K., and ALLSHIRE, R.C. Telomere reduction in human colorectal carcinoma and with aging. Nature 346, 866-868, 1990.
20. HARPER, J.W., ADAMI, G.R., WEI, N., KEYOMARSI, K., and ELLEDGE, S. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816, 1993.
21. HAYFLICK, L. and MOORHEAD, P. The serial cultivation of human diploid strains. Exp. Cell Res. 25, 585-621, 1961.
22. HUNTER, T. and PINES, J. Cyclins and Cancer II: Cyclin D and CDK inhibitors come of age. Cell 79, 573-582, 1994.
23. KASTAN, M.B., ZHAN, Q., EL-DEIRY, W.S., CARRIER, F., JACKS T., WALSH, W.V., PLUNKETT, B.S., VOGELSTEIN, B., and FORNACE, A.J., JR. A mammalian cell cycle checkpoint pathway utilizing p53 and Gadd45 is defective in Ataxia-telangiectasia. Cell 71, 587-597, 1992.
24. KIM, N.W., PLATYSZEK, M.A., PROWSE, K.R., HARLEY, C.B., WEST, M.D., HO, P.L., COVIELLO, G.M., WRIGHT, W.E., WEINRICH, S.L., and SHAY, J.W. Specific association of telomerase with immortal cells and cancer. Science 266, 2011-2014, 1994.
25. LEVY, M.L., ALLSOPP, R.C., FUTCHER, A.B., GREIDER, C.W., and HARLEY, C.B. Telomere end-replication problem and cell senescence. J. Mol. Biol. 225, 951-960. 1992.
26. LIVINGSTONE, L.R., WHITE, A., SPROUSE, J., LIVANOS, E., JACKS, T., and TLSTY, T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923-935, 1992.
27. MEYNE, J., RATLIFF, R.L., and MOYZIS, R.K. Conservation of human telomere sequence (TTAGGG)n among vertebrates, Proc. Natl. Acad. Sci. USA 86, 7049-53, 1989.
28. MICHIELI, P., CHEDID, M., LIN, D., PIERCE, J.H., MERCER, W.E., and GIVOL, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54, 3391-3395, 1994.
29. MORIN, G. The human telomere terminal transferase is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59, 521-529, 1990.
30. NODA, A., NING, Y., VENABLE, S.F., PEREIRA-SMITH, O.M., and SMITH, J.R. Cloning the senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211, 90-98, 1994.
31. OLOVNIKOV, A.M. A theory of marginotomy. Dokaly Biochem. 201, 394-397, 1971.
32. RUBELJ, I. and PEREIRA-SMITH, O.M. SV40-Transformed human cells in crisis exhibit changes that occur in normal cellular senescence. Exp. Cell Res. 211, 82-89, 1994.
33. SHAY, J.W., WRIGHT, W.E., and WERBIN, H. Defining the molecular mechanisms of human cell immortalization. Biochem. Biophys. Acta 1072, 1-7, 1991.
34. SHERR, C.J. G1 phase progression: Cycling on cue. Cell 79, 551-555, 1994.
35. SHERWOOD, S.W., RUSH, D., ELLSWORTH, J.L., and SCHIMKE, R.T. Defining cellular senescence in IMR-90 cells: A flow cytornertric analysis. Proc. Natl. Acad. Sci. USA 85, 9086-9090, 1989.
36. STEIN, G.H., BESSON, M., GORDON, L. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblast. Science 249, 666-669, 1990.
37. VAZIRI, H., SCHACHTER, F., UCHIDA, I., WEI, L., ZHU, X., EFFROSS, R., COHEN, D., and HARLEY, C.B. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52, 661-667, 1993.
38. VAZIRI, H., DRAGOWSKA, W., ALLSOPP, R.C., THOMAS, T.E., HARLEY, C.B., and LANSDORP, P.L. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA 91, 9857-9860, 1994.
39. WATSON, J.D. Origin of the concatameric T4 DNA. Nature New Biol. 239, 197-201, 1972.
40. WRIGHT, W.E. and SHAY, J.W. Telomere positional effects and the regulation of cellular senescence. Trends Genet. 8, 193-197, 1992.
41. XIONG, Y., HANNON, G.J., ZHANG, H., CASSO, D., KOBAGASHI, R., BEACH, D. p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-706, 1993.
42. YIN, Y., TAINSKY, M.A., BISCHOFF, F.Z., STRONG, L.C., and WAHL, G.M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70, 937-948, 1992.